tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
Holding NTLA?
Track your performance easily

Intellia Therapeutics (NTLA) Financial Statements

3,132 Followers

Intellia Therapeutics Financial Overview

Intellia Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.445; its P/E ratio is -2.41; Intellia Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-1.34. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 9.11M$ 6.96M$ 28.93M$ -1.92M$ 11.99M
Gross Profit$ 9.11M$ 6.96M$ 28.93M$ -1.92M$ 11.99M
EBIT$ -135.71M$ -146.97M$ -114.00M$ -132.16M$ -131.11M
EBITDA$ -133.10M$ -139.09M$ -111.49M$ -110.11M$ -128.82M
Net Income Common Stockholders$ -135.71M$ -147.18M$ -107.44M$ -132.16M$ -122.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 658.11M$ 691.07M$ 791.29M$ 912.22M$ 854.79M
Total Assets$ 1.17B$ 1.19B$ 1.26B$ 1.30B$ 1.24B
Total Debt$ 101.62M$ 106.30M$ 110.86M$ 115.35M$ 118.34M
Net Debt$ -556.49M$ -584.77M$ -680.43M$ -796.88M$ -736.45M
Total Liabilities$ 210.74M$ 220.47M$ 223.45M$ 250.81M$ 205.94M
Stockholders Equity$ 962.62M$ 971.06M$ 1.04B$ 1.05B$ 1.04B
Cash Flow-
Free Cash Flow$ -86.12M$ -59.20M$ -123.17M$ -94.57M$ -105.71M
Operating Cash Flow$ -84.84M$ -58.19M$ -120.66M$ -93.05M$ -101.38M
Investing Cash Flow$ -7.71M$ -24.19M$ 5.90M$ 45.94M$ 79.50M
Financing Cash Flow$ 82.19M$ 41.25M$ 59.99M$ 106.48M$ 19.10M
Currency in USD

Intellia Therapeutics Earnings and Revenue History

Intellia Therapeutics Debt to Assets

Intellia Therapeutics Cash Flow

Intellia Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis